Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

NAMSW NewAmsterdam Pharma Company NV

14,78

0,00 (0,00%)

Nach Börsenschluss

Zuletzt aktualisiert: 22:54:57

Verzögert um 15 Minuten

Form 144 - Report of proposed sale of securities

="/Images/box-checked.jpg" alt="Checkbox checked">

144: Remarks and Signature

Remarks

Date of Notice

10/01/2024

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

/s/ Louise Kooij

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

NewAmsterdam Pharma Comp... (NASDAQ:NAMSW)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more NewAmsterdam Pharma Comp... Charts.

NewAmsterdam Pharma Comp... (NASDAQ:NAMSW)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more NewAmsterdam Pharma Comp... Charts.

News NewAmsterdam Pharma Company NV

Form 144 - Report of proposed sale of securities
Freitag 10 Januar 2025 (3 Stunden vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 10 Januar 2025 (11 Stunden vor) • Edgar (US Regulatory)

NewAmsterdam Pharma Highlights 2024 Achievements and Outlines 2025 Strategic Priorities
Freitag 10 Januar 2025 (11 Stunden vor) • GlobeNewswire Inc.

NewAmsterdam Pharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 9 Januar 2025 (1 Tag vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 8 Januar 2025 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Dienstag 7 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Form S-8 - Securities to be offered to employees in employee benefit plans
Dienstag 7 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Montag 6 Januar 2025 (4 Tage vor) • Edgar (US Regulatory)

Weitere NewAmsterdam Pharma Company NV News-Artikel

Invesco QQQ Trust Series 1

Gold vs US Dollar

Euro vs US Dollar

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen